newsfilter
← Latest News
GlobeNewswire·

Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference

Exceeded 10,000 patients treated to date with CARVYKTI® (ciltacabtagene autoleucel; cilta-cel)Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell